GSK PLC 13D/13G Filings for Innoviva, Inc. (INVA)

GSK PLC 13D and 13G filings for Innoviva, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-05-25
4:24 pm
Sale		2021-05-2013DInnoviva, Inc.
INVA		GSK PLC0
0.000%		-32,005,260decrease
(Position Closed)		Filing
2021-02-12
5:13 pm
Unchanged		2021-02-1213DInnoviva, Inc.
INVA		GSK PLC32,005,260
31.600%		0
(Unchanged)		Filing